Abstract
In medical diagnosis context, consideration for missing diagnosis and false diagnosis of disease types are important clinical considerations for disease treatment decisions. Effect and impact of disease types especially on others forms the basis for critical clinical decisions. Impact and consequences varies across disease types especially for communicable and non-communicable diseases. Increasing use of predictive techniques owing to high use of connected internet of things devices in healthcare provides sufficient opportunity for potential benefit assessment of predictive modeling impact on disease treatment management. Effective and efficient management of non-communicable diseases such as hypertension is hampered in part by instances of multiple forms of its occurrence in patients leading to treatment management complications. Probing predictive modeling effect and implications for clinical decisions to enhance patient treatment outcome provides important evidence-based justifications for its use in healthcare systems. Effective predictive technique use is significantly dependent on areas of its application and the consequences of error for its use in context.
Author summary The use of macro average score in class imbalance context is to treat all classes equally regardless of variations in class distributions. Clinical significance as identified in this research work includes the determination of effective and accurate predictive modeling techniques for real-world application context where class distribution variation is a characteristic feature. Identifying various sections of healthcare delivery process ensures effective application of predictive modeling techniques for the required impact on clinical decisions and its effect on patient outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Formal request for data collection was made by Kwame Nkrumah University of Science and Technology through the Department of Computer science in a corresponding letter dated 25th march, 2022 referenced DCS/S.1/VOL.1 which was approved by the management of Kwahu Government Hospital under the authorization of the medical director on 30th march, 2022. A scanned copy is attached for perusal.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Research dataset used is available upon reasonable request
